Abstract:Macroautophagy/autophagy is a highly conserved evolutionary mechanism involving lysosomes for the degradation of cytoplasmic components including organelles. The constitutive, basal level of autophagy is fundamental for preserving cellular homeostasis; however, alterations in autophagy can cause disease pathogenesis, including cancer. The role of autophagy in cancer is particularly complicated, since this process acts both as a tumor suppressor in precancerous stages but facilitates tumor progression during carcinogenesis and later stages of cancer progression. This shift between anti-tumor and pro-tumor roles may be influenced by genetic and environmental factors modulating key pathways such as those involving autophagy-related proteins, the PI3K-AKT-MTOR axis, and AMPK, which often show dysregulation in tumors. Autophagy regulates various cellular functions, including metabolism of glucose, glutamine, and lipids, cell proliferation, metastasis, and several types of cell death (apoptosis, ferroptosis, necroptosis and immunogenic cell death). These multifaceted roles demonstrate the potential of autophagy to affect DNA damage repair, cell death pathways, proliferation and survival, which are critical in determining cancer cells' response to chemotherapy. Therefore, targeting autophagy pathways presents a promising strategy to combat chemoresistance, as one of the major reasons for the failure in cancer patient treatment. Furthermore, autophagy modulates immune evasion and the function of immune cells such as T cells and dendritic cells, influencing the tumor microenvironment and cancer's biological behavior. However, the therapeutic targeting of autophagy is complex due to its dual role in promoting survival and inducing cell death in cancer cells, highlighting the need for strategies that consider both the beneficial and detrimental effects of autophagy modulation in cancer therapy. Hence, both inducers and inhibitors of autophagy have been introduced for the treatment of cancer. This review emphasizes the intricate interplay between autophagy, tumor biology, and immune responses, offering insights into potential therapeutic approaches that deploy autophagy in the cancer suppression.

Enzyme-based autophagy in anti-neoplastic management: From molecular mechanisms to clinical therapeutics

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Amino Acid Degrading Enzymes and Autophagy in Cancer Therapy

Autophagy in cancer development, immune evasion, and drug resistance

Autophagy and Cancer Drug Resistance in Dialogue: Pre-clinical and Clinical Evidence.

Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies

Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells

The Molecular Mechanism of Autophagy Associated with Cancers

Autophagy as a molecular target for cancer treatment

Autophagy in Cancer Therapy: Progress and Issues

Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer

Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients

Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy

Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy

Autophagy Regulators in Cancer

Autophagy modulation in cancer therapy

Nanotherapeutics targeting autophagy regulation for improved cancer therapy

Regulation of autophagy in tumor cells and application of targeting autophagy in cancer

Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy

Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy

Pharmaceutical Agents for Targeting Autophagy and Their Applications in Clinics